Osteoporosis is a metabolic bone disease defined by reduced bone mineral density and disrupted trabecular architecture, resulting in an increased propensity for fragility fractures. Unlike osteopetrosis, which features excessively dense but brittle bones, osteoporosis involves a net loss of bone mass, primarily driven by an imbalance in bone remodeling—where osteoclast-mediated bone resorption outpaces osteoblast-mediated bone formation. The condition can be primary (postmenopausal, age-related) or secondary to medications (glucocorticoids, aromatase inhibitors), endocrine disorders (hyperparathyroidism, Cushing’s), or prolonged immobilization. It is clinically distinguished from osteomalacia, a defect in mineralization causing soft bones, and from osteopenia, which represents a milder reduction in bone density (T-score -1.0 to -2.5) that precedes osteoporosis but does not itself confer the same fracture risk. The most clinically relevant forms include M81.0 - age-related/postmenopausal osteoporosis (M81.0), M80.0- osteoporosis with current pathological fracture (M80.0-), and M81.8 - drug-induced or secondary osteoporosis (M81.8). In summary, while osteopenia is a warning sign, osteoporosis defines the threshold at which bone strength is sufficiently compromised to cause pathologic fractures with minimal trauma.
The word entered English in the 1840s as osteoporosis (noun), borrowed from French ostéoporose, from Greek ὀστέον (ostéon) “bone” + πόρος (póros) “pore” + -ωσις (-ōsis) “condition,” literally “porous bone condition.” The root por- (“pore, passage”) links osteoporosis to terms such as porosity and porotic. The combining form osteo- (“bone”) connects osteoporosis to osteopathy, osteomyelitis, osteosarcoma, and the entire -osis family of conditions. The adjective osteoporotic appeared by the 1870s, following standard Greek-derived adjectival formation.
🔀 ALIASES / ALTERNATE TERMS
Osteoporotic(adjective form — “osteoporotic fracture,” “osteoporotic vertebral compression fracture,” “osteoporotic hip fracture”)
Porous bone disease(lay term; sometimes “brittle bone disease,” though that more often refers to osteogenesis imperfecta)
Bone thinning(lay descriptive term)
Low bone mass(formal clinical descriptor; T-score ←1.0, but osteoporosis is diagnosed at ←2.5)
M81.0|Age-Related Osteoporosis(senile or postmenopausal osteoporosis; primary form — M81.0)
M80.0-|Osteoporosis with Current Pathological Fracture(fragility fracture directly due to osteoporosis; requires site/laterality and encounter — M80.0xxA/D/S)
M81.8|Secondary Osteoporosis(drug-induced, glucocorticoid-induced, or due to medical conditions — M81.8)
M85.3-|Transient Osteoporosis of Hip(rare, self-limiting condition causing temporary bone loss, often in pregnancy or middle-aged men — M85.30-)
Osteoporosis circumscripta(archaic term, associated with Paget’s disease of bone)
Senile Osteoporosis(synonym for age-related, particularly in elderly men and women — M81.0)
Postmenopausal Osteoporosis(estrogen-deficiency form, most common subtype; coded M81.0)
🔗 RELATED TERMS
Osteopetrosis — the opposite of osteoporosis; a rare genetic disorder causing abnormally dense, marble-like bones that are paradoxically brittle.
Osteopenia — a milder form of reduced bone density (T-score between -1.0 and -2.5), a precursor to osteoporosis but without the same fracture risk.
Osteomalacia — defective mineralization of the bone matrix leading to soft bones, often due to vitamin D deficiency; distinct because bone volume may be normal but mineral content is low.
Osteosclerosis — focal or generalized increase in bone density; opposite of osteoporosis in localized areas.
Hyperparathyroidism — a common secondary cause of osteoporosis through excessive osteoclastic bone resorption.
Bone Remodeling — the lifelong process of bone turnover; osteoporosis results from a net negative balance in this cycle.
Osteoclast — bone-resorbing cell whose overactivity contributes to osteoporotic bone loss.
Osteoblast — bone-forming cell; reduced function or number contributes to inadequate bone formation.
RANKL — receptor activator of nuclear factor kappa-Β ligand, a key regulator of osteoclast development; targeted by denosumab.
Pathological Fracture — a fracture that occurs in bone weakened by disease; in osteoporosis, coded as M80.- with the underlying osteoporosis as the cause.
FRAX — WHO Fracture Risk Assessment Tool used to estimate 10-year probability of hip and major osteoporotic fractures.
Dual-Energy X-ray Absorptiometry (DXA) — gold-standard diagnostic test for measuring bone mineral density.
CODING CORNER
🏥 ICD-10-CM CODES
Osteoporosis Without Current Pathological Fracture (M81.-)
Office outpatient visit, established patient, 15 minutes (often used for osteoporosis medication monitoring)
⚠️ Coding Note: Osteoporosis codes from M81.- are used when there is no active pathological fracture. When a fragility fracture is present and the osteoporosis is the underlying cause, sequence the M80.- code as the principal diagnosis, specifying both site (e.g., M80.08XA for vertebra) and encounter type (A, D, S). For screening without symptoms or established disease, use Z13.820. Undercoding is common on inpatient profee claims when fracture documentation lacks an explicit link to osteoporosis—terms such as “femur fracture,” “fall,” or “generalized weakness” without mention of osteoporotic etiology should prompt a query for “pathological fracture due to osteoporosis.” Always assign the most specific site/laterality and 7th-character encounter code; for subsequent encounters with routine healing, use “D”; for late effects (nonunion, malunion), use sequela “S.” Payers may require prior authorization for DXA studies; Medicare covers every two years for qualifying individuals.
Crystal's Coder Hub